Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CENTRAL NERVOUS SYSTEM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | CENTRAL NERVOUS SYSTEM |
| Key Genes/Proteins | ACTB, AIF1, ALZHEIMER, amyotrophic lateral sclerosis, ANXIETY, APOE |
| Related Diseases | aging, Alzheimer'S Disease |
graph TD
CENTRAL_NERVOUS_SYSTEM["CENTRAL NERVOUS SYSTEM"]
CENTRAL_NERVOUS_SYSTEM -->|"modulates"| Hepatocellular_Carcinoma["Hepatocellular Carcinoma"]
CENTRAL_NERVOUS_SYSTEM -->|"modulates"| Glioblastoma_Multiforme["Glioblastoma Multiforme"]
CENTRAL_NERVOUS_SYSTEM -->|"expressed in"| Autophagy["Autophagy"]
GPR37["GPR37"] -->|"expressed in"| CENTRAL_NERVOUS_SYSTEM
BI_hTFR1["BI-hTFR1"] -->|"mediates"| CENTRAL_NERVOUS_SYSTEM
AQP4["AQP4"] -->|"expressed in"| CENTRAL_NERVOUS_SYSTEM
PIEZO1["PIEZO1"] -->|"involved_in"| CENTRAL_NERVOUS_SYSTEM
Gut_Microbiota["Gut Microbiota"] -->|"modulates"| CENTRAL_NERVOUS_SYSTEM
Gut_Brain_Axis["Gut-Brain Axis"] -->|"mediates"| CENTRAL_NERVOUS_SYSTEM
Microglia["Microglia"] -->|"expressed in"| CENTRAL_NERVOUS_SYSTEM
Microbiota_Gut_Brain_Axis["Microbiota-Gut-Brain Axis"] -->|"interacts"| CENTRAL_NERVOUS_SYSTEM| Target | Relation | Type | Str |
|---|---|---|---|
| Hepatocellular Carcinoma | modulates | disease | 0.95 |
| Neuromyelitis Optica Spectrum Disorder | involved_in | disease | 0.90 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | involved_in | disease | 0.90 |
| Glioblastoma Multiforme | modulates | disease | 0.85 |
| Limited Neuroregeneration | associated_with | phenotype | 0.85 |
| Self-Repair Potential | associated_with | phenotype | 0.85 |
| limited self-repair potential | associated_with | phenotype | 0.85 |
| Autophagy | expressed_in | process | 0.80 |
| Cellular Senescence | expressed_in | process | 0.80 |
| Glioblastoma Multiforme | regulates | disease | 0.80 |
| Neuroregeneration | associated_with | process | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Bi-Htfr1 | mediates | drug | 0.98 |
| Bi-Htfr1 | targets | drug | 0.96 |
| CRISPR | targets | process | 0.95 |
| AQP4 | expressed_in | protein | 0.95 |
| PIEZO1 | involved_in | gene | 0.95 |
| SHH | expressed_in | protein | 0.95 |
| AQUAPORINS | expressed_in | protein | 0.95 |
| AAV-PHP.eB | targets | drug | 0.95 |
| Gut Microbiota | associated_with | process | 0.95 |
| Cns Extracellular Matrix | expressed_in | biomarker | 0.95 |
| BI-hTFR1 | mediates | drug | 0.95 |
| Viral Vector Gene Therapy | targets | drug | 0.95 |
| Gut-Brain Axis | mediates | pathway | 0.95 |
| Multiple Sclerosis | associated_with | disease | 0.95 |
| Aav-Php.Eb | targets | compound | 0.95 |
| Microbiota-Gut-Brain Axis | interacts_with | pathway | 0.95 |
| Microglia | expressed_in | cell_type | 0.95 |
| HCN | expressed_in | protein | 0.95 |
| TREM2 | expressed_in | protein | 0.92 |
| AAV-PHP.eB | involved_in | drug | 0.92 |
| TFRC | associated_with | protein | 0.92 |
| AQP1 | expressed_in | gene | 0.90 |
| AAVT42 | targets | drug | 0.90 |
| AQP5 | expressed_in | gene | 0.90 |
| CNS Extracellular Matrix Components | expressed_in | protein | 0.90 |
| Tissue-Sensing T Cells | targets | cell_type | 0.90 |
| MICROBIOTA | communicates_with | cell_type | 0.90 |
| canonical SHH pathway | involved_in | pathway | 0.90 |
| gut | interacts_with | brain_region | 0.90 |
| sleep | associated_with | process | 0.90 |
| Piezo1 | associated_with | gene | 0.90 |
| AQP9 | expressed_in | gene | 0.90 |
| AQP3 | expressed_in | gene | 0.90 |
| Oligonucleotide Transport Vehicle | involved_in | drug | 0.88 |
| FUS | expressed_in | protein | 0.85 |
| Gut-Brain Axis | modulates | pathway | 0.85 |
| non-canonical SHH pathway | involved_in | pathway | 0.85 |
| Myeloid Cells | involved_in | cell_type | 0.85 |
| TAU | expressed_in | protein | 0.85 |
| HCN1 | expressed_in | gene | 0.85 |
| Crispr-Cas9 Gene Therapy | involved_in | drug | 0.85 |
| Gut Microbiota | interacts_with | cell_type | 0.85 |
| Alpha-Synuclein Progression | involved_in | process | 0.85 |
| VNAR Antibodies | targets | drug | 0.85 |
| Protein Filamentous Assembly | expressed_in | process | 0.85 |
| Autophagy | involved_in | process | 0.85 |
| FTLD-TDP Type C | expressed_in | disease | 0.85 |
| Neuroinflammation | expressed_in | process | 0.85 |
| Vagus Nerve Pathway | mediates | pathway | 0.85 |
| Nanoparticles | associated_with | compound | 0.82 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CENTRAL NERVOUS SYSTEM in their description or question text
No additional research found